16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      DNA Damage, Repair, and Cancer Metabolism

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although there has been a renewed interest in the field of cancer metabolism in the last decade, the link between metabolism and DNA damage/DNA repair in cancer has yet to be appreciably explored. In this review, we examine the evidence connecting DNA damage and repair mechanisms with cell metabolism through three principal links. (1) Regulation of methyl- and acetyl-group donors through different metabolic pathways can impact DNA folding and remodeling, an essential part of accurate double strand break repair. (2) Glutamine, aspartate, and other nutrients are essential for de novo nucleotide synthesis, which dictates the availability of the nucleotide pool, and thereby influences DNA repair and replication. (3) Reactive oxygen species, which can increase oxidative DNA damage and hence the load of the DNA-repair machinery, are regulated through different metabolic pathways. Interestingly, while metabolism affects DNA repair, DNA damage can also induce metabolic rewiring. Activation of the DNA damage response (DDR) triggers an increase in nucleotide synthesis and anabolic glucose metabolism, while also reducing glutamine anaplerosis. Furthermore, mutations in genes involved in the DDR and DNA repair also lead to metabolic rewiring. Links between cancer metabolism and DNA damage/DNA repair are increasingly apparent, yielding opportunities to investigate the mechanistic basis behind potential metabolic vulnerabilities of a substantial fraction of tumors.

          Related collections

          Most cited references90

          • Record: found
          • Abstract: not found
          • Article: not found

          On the origin of cancer cells.

          O WARBURG (1956)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Emerging Hallmarks of Cancer Metabolism.

            Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations. A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass. The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation, and the tumor microenvironment. In this Perspective, we have organized known cancer-associated metabolic changes into six hallmarks: (1) deregulated uptake of glucose and amino acids, (2) use of opportunistic modes of nutrient acquisition, (3) use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, (4) increased demand for nitrogen, (5) alterations in metabolite-driven gene regulation, and (6) metabolic interactions with the microenvironment. While few tumors display all six hallmarks, most display several. The specific hallmarks exhibited by an individual tumor may ultimately contribute to better tumor classification and aid in directing treatment.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              On the Origin of Cancer Cells

              O WARBURG (1956)
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/508273
                URI : http://frontiersin.org/people/u/510456
                URI : http://frontiersin.org/people/u/510308
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                05 February 2018
                2018
                : 8
                : 15
                Affiliations
                [1] 1Department of Cancer Biology, Institute of Cancer Research , London, United Kingdom
                [2] 2Division of Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London , London, United Kingdom
                Author notes

                Edited by: Leonardo Freire-de-Lima, Universidade Federal do Rio de Janeiro, Brazil

                Reviewed by: Daniele Vergara, University of Salento, Italy; Bernd Groner, Georg Speyer Haus, Germany; Vandna Kukshal, Washington University in St. Louis, United States

                *Correspondence: George Poulogiannis, george.poulogiannis@ 123456icr.ac.uk

                Specialty section: This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2018.00015
                5807667
                29459886
                c8fb0b77-9f02-4f87-a2fb-07d38673cf0b
                Copyright © 2018 Turgeon, Perry and Poulogiannis.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 15 December 2017
                : 17 January 2018
                Page count
                Figures: 2, Tables: 0, Equations: 0, References: 83, Pages: 8, Words: 5937
                Funding
                Funded by: Cancer Research UK 10.13039/501100000289
                Award ID: C59824/A25044
                Categories
                Oncology
                Mini Review

                Oncology & Radiotherapy
                metabolism,dna repair,dna damage,cancer,reactive oxygen species
                Oncology & Radiotherapy
                metabolism, dna repair, dna damage, cancer, reactive oxygen species

                Comments

                Comment on this article